Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax." | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."	Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease	Not yet recruiting	Phase 1	2025-09-15		NCT07172724

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CT Vacinas - Centro de Tecnologia em Vacinas/Universidade Federal de Minas Gerais	1
Federal University of Minas Gerais	20
Financiadora de Estudos e Projetos	9
Fundação de Amparo à Pesquisa do Estado de São Paulo	33
INCTV National Institute of Vaccine Science and Technology	1
The Ministry of Science, Technology and Innovation, Brazil	1
University of Sao Paulo	128

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centro de Pesquisas Clínicas (CPC) do Hospital das Clínicas (HC) da UFMG/ Filial Ebserh	Belo Horizonte	Brazil	1